Cost-effectiveness of colorectal cancer screening in the average risk population

Moshe Leshno; Zamir Halpern; Nadir Arber

doi:10.1023/A:1024488007043

Cost-effectiveness of colorectal cancer screening in the average risk population

Moshe Leshno^*, Zamir Halpern, Nadir Arber

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

Colorectal cancer (CRC) is a leading cause of cancer death in North America and in Israel. Risk of CRC increases exponentially with age starting at the age of 50 years. Therefore, people older than 50 years are being considered as an average risk population for CRC. The objective of this study was to obtain an improved assessment of the cost-effectiveness analysis of screening for CRC in the average risk population by using a more accurate technique, namely the Partially Observed Markov Decision Process (POMDP). We conducted a cost-effectiveness analysis within the specific probability rates and costs in Israel. This study revealed that it is highly cost-effective to screen average-risk asymptomatic individuals.

Original language	English
Pages (from-to)	165-174
Number of pages	10
Journal	Health Care Management Science
Volume	6
Issue number	3
DOIs	https://doi.org/10.1023/A:1024488007043
State	Published - Aug 2003

Keywords

Carcinoma of colon and rectum
Cost-effectiveness analysis
Partially observed Markov decision process
Screening

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1023/A:1024488007043

Cite this

@article{d6f45e4c629b4c3d8b4bcb565536bda4,

title = "Cost-effectiveness of colorectal cancer screening in the average risk population",

abstract = "Colorectal cancer (CRC) is a leading cause of cancer death in North America and in Israel. Risk of CRC increases exponentially with age starting at the age of 50 years. Therefore, people older than 50 years are being considered as an average risk population for CRC. The objective of this study was to obtain an improved assessment of the cost-effectiveness analysis of screening for CRC in the average risk population by using a more accurate technique, namely the Partially Observed Markov Decision Process (POMDP). We conducted a cost-effectiveness analysis within the specific probability rates and costs in Israel. This study revealed that it is highly cost-effective to screen average-risk asymptomatic individuals.",

keywords = "Carcinoma of colon and rectum, Cost-effectiveness analysis, Partially observed Markov decision process, Screening",

author = "Moshe Leshno and Zamir Halpern and Nadir Arber",

year = "2003",

month = aug,

doi = "10.1023/A:1024488007043",

language = "אנגלית",

volume = "6",

pages = "165--174",

journal = "Health Care Management Science",

issn = "1386-9620",

publisher = "Kluwer Academic Publishers",

number = "3",

}

TY - JOUR

T1 - Cost-effectiveness of colorectal cancer screening in the average risk population

AU - Leshno, Moshe

AU - Halpern, Zamir

AU - Arber, Nadir

PY - 2003/8

Y1 - 2003/8

N2 - Colorectal cancer (CRC) is a leading cause of cancer death in North America and in Israel. Risk of CRC increases exponentially with age starting at the age of 50 years. Therefore, people older than 50 years are being considered as an average risk population for CRC. The objective of this study was to obtain an improved assessment of the cost-effectiveness analysis of screening for CRC in the average risk population by using a more accurate technique, namely the Partially Observed Markov Decision Process (POMDP). We conducted a cost-effectiveness analysis within the specific probability rates and costs in Israel. This study revealed that it is highly cost-effective to screen average-risk asymptomatic individuals.

AB - Colorectal cancer (CRC) is a leading cause of cancer death in North America and in Israel. Risk of CRC increases exponentially with age starting at the age of 50 years. Therefore, people older than 50 years are being considered as an average risk population for CRC. The objective of this study was to obtain an improved assessment of the cost-effectiveness analysis of screening for CRC in the average risk population by using a more accurate technique, namely the Partially Observed Markov Decision Process (POMDP). We conducted a cost-effectiveness analysis within the specific probability rates and costs in Israel. This study revealed that it is highly cost-effective to screen average-risk asymptomatic individuals.

KW - Carcinoma of colon and rectum

KW - Cost-effectiveness analysis

KW - Partially observed Markov decision process

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=0642335538&partnerID=8YFLogxK

U2 - 10.1023/A:1024488007043

DO - 10.1023/A:1024488007043

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:0642335538

SN - 1386-9620

VL - 6

SP - 165

EP - 174

JO - Health Care Management Science

JF - Health Care Management Science

IS - 3

ER -

Cost-effectiveness of colorectal cancer screening in the average risk population

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this